Marker Therapeutics Inc Share Price Today: Live Updates & Key Insights
Marker Therapeutics Inc share price today is $1.32, up 1.52%. The stock opened at $1.29 against the previous close of $1.32, with an intraday high of $1.38 and low of $1.29.
Marker Therapeutics Inc Share Price Chart
Marker Therapeutics Inc
Marker Therapeutics Inc Share Price Performance
Marker Therapeutics Inc Institutional Holdings
Marker Therapeutics Inc Market Status
Marker Therapeutics Inc Fundamentals
Market Cap 17.34 M
PB Ratio 1.215
PE Ratio 0.0
Enterprise Value 4.75 M
Total Assets 19070997.00 M
Volume 131457
Marker Therapeutics Inc Company Financials
About Marker Therapeutics Inc & investment objective
Company Information Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.
Organisation Biotechnology
Employees 5
Industry Biotechnology
CEO Dr. Juan F. Vera M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Marker Therapeutics Inc FAQs
What is the share price of Marker Therapeutics Inc today?
The current share price of Marker Therapeutics Inc is $1.32.
Can I buy Marker Therapeutics Inc shares in India?
Yes, Indian investors can buy Marker Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Marker Therapeutics Inc shares in India?
You can easily invest in Marker Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Marker Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Marker Therapeutics Inc.
Can I buy fractional shares of Marker Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Marker Therapeutics Inc?
Marker Therapeutics Inc has a market cap of $17.34 M.
In which sector does Marker Therapeutics Inc belong?
Marker Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Marker Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Marker Therapeutics Inc?
The PE ratio of Marker Therapeutics Inc is N/A and the PB ratio is 1.22.